Maximum quantity allowed is 999
Please select the quantity
CAS RN: 251456-60-7 | Product Number: D4188
4-(Dimethylamino)-N-[7-(hydroxyamino)-7-oxoheptyl]benzamide
Purity: >97.0%(HPLC)
Synonyms:
- M 344
Product Documents:
Size | Unit Price | Same Day | 2-3 Business Days | Other Lead Time | Shipping Information |
---|---|---|---|---|---|
20MG |
$219.00
|
23 | 0 | Contact Us | |
100MG |
$724.00
|
7 | 0 | Contact Us |
* Please contact our distributors or
TCI
to order our products. The above prices do not include freight cost, customs, and other charges to the destination.
* The storage conditions are subject to change without notice.
Product Number | D4188 |
Purity / Analysis Method | >97.0%(HPLC) |
Molecular Formula / Molecular Weight | C__1__6H__2__5N__3O__3 = 307.39 |
Physical State (20 deg.C) | Solid |
Storage Temperature | Refrigerated (0-10°C) |
Condition to Avoid | Heat Sensitive |
Packaging and Container | 100MG-Glass Bottle with Plastic Insert (View image), 20MG-Glass Bottle with Plastic Insert (View image) |
CAS RN | 251456-60-7 |
Reaxys Registry Number | 8570090 |
PubChem Substance ID | 160871269 |
MDL Number | MFCD03453554 |
Specifications
Appearance | White to Light yellow powder to crystal |
Purity(HPLC) | min. 97.0 area% |
Elemental analysis(Nitrogen) | 13.20 to 13.80 % |
NMR | confirm to structure |
Properties (reference)
Melting Point | 152 °C |
GHS
Related Laws:
Transport Information:
H.S.code* | 2928.00-000 |
Application
M344: A Histone Deacetylase (HDAC) Inhibitor
Histone deacetylase (HDAC) inhibitors are emerging therapeutic agents with potential for disruption of critical cellular processes in cancer cells. M344 is a synthesized HDAC inhibitor that induces growth inhibition, cell cycle arrest, and apoptosis in cancer cells. (The product is for research purpose only.)
References
- Structural Snapshots of Human HDAC8 Provide Insights into the Class I Histone Deacetylases
- Amide Analogues of Trichostatin A as Inhibitors of Histone Deacetylase and Inducers of Terminal Cell Differentiation
- The benzamide M344, a novel histone deacetylase inhibitor, significantly increases SMN2 RNA/protein levels in spinal muscular atrophy cells
- M344 is a novel synthesized histone deacetylase inhibitor that induces growth inhibition, cell cycle arrest, and apoptosis in human endometrial cancer and ovarian cancer cells
- Histone deacetylase inhibitor M344 inhibits cell proliferation and induces apoptosis in human THP-1 leukemia cells
- Selective histonedeacetylase inhibitor M344 intervenes in HIV-1 latency through increasing histone acetylation and activation of NF-kappaB
PubMed Literature
Articles/Brochures
TCIMAIL
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.